First Time Loading...

RemeGen Co Ltd
HKEX:9995

Watchlist Manager
RemeGen Co Ltd Logo
RemeGen Co Ltd
HKEX:9995
Watchlist
Price: 31.4 HKD -2.79% Market Closed
Updated: May 13, 2024

RemeGen Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

RemeGen Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
RemeGen Co Ltd
HKEX:9995
Income from Continuing Operations
-¥1.5B
CAGR 3-Years
-29%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Income from Continuing Operations
-¥6.7B
CAGR 3-Years
16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Income from Continuing Operations
-¥1B
CAGR 3-Years
-1%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Income from Continuing Operations
¥1.2B
CAGR 3-Years
22%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Income from Continuing Operations
¥7.5B
CAGR 3-Years
26%
CAGR 5-Years
35%
CAGR 10-Years
50%
Imeik Technology Development Co Ltd
SZSE:300896
Income from Continuing Operations
¥1.3B
CAGR 3-Years
62%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is RemeGen Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-1.5B CNY

Based on the financial report for Dec 31, 2023, RemeGen Co Ltd's Income from Continuing Operations amounts to -1.5B CNY.

What is RemeGen Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-41%

Over the last year, the Income from Continuing Operations growth was -51%. The average annual Income from Continuing Operations growth rates for RemeGen Co Ltd have been -29% over the past three years , -41% over the past five years .